US FDA Approved Zydus Lifesciences’ Generic Drug to Treat Myxedema Coma

As per a financial exchange documenting, Zydus Lifesciences Restricted, previously Cadila Medical services Restricted, has gotten endorsement from the US wellbeing controller to showcase a conventional item. In a BSE statement, the company said that Zydus has received final approval from the United States Food and Drug Administration (USFDA) for levothyroxine sodium for injection, 100 […]

Continue Reading

US FDA Approves Rett Syndrome Drug by Acadia

The US FDA granted Acadia Pharmaceuticals’ DAYBUE (trofinetide) approval for the treatment of Rett syndrome in adults and children over the age of two last Friday. DAYBUE is the first and only medication approved for the treatment of Rett syndrome. Acadia and the Rett community have reached a significant turning point today. Steve Davis, CEO […]

Continue Reading

Moderna’s Omicron-focused Vaccine Better than Original COVID-19 Vaccine

Moderna Inc. claimed that its Omicron-focused COVID-19 vaccines had improved immune responses against BA.4 and BA.5 sub-variants of Omicron, found Moderna’s latest study. Data suggests that in adults who had been vaccinated and received booster shots, both of Moderna’s Omicron-focused vaccines, including mRNA-1273.214 and mRNA-1273.222, has produced high antibody response against BA.4 and BA.5 sub-variants […]

Continue Reading

Researchers from IIT Jodhpur Discovered COVID-19 RNA Variations and Implications

Using cutting-edge genome sequencing techniques, researchers at the Indian Institute of Technology (IIT), Jodhpur, have discovered variants in the COVID-19 virus’s RNA, according to officials. The fixation of these intra-host variations and mutations that results in variants have both been researched by experts. The journal “Nucleic Acid Research” has published the findings of the two-phase […]

Continue Reading